Entity Address, City or Town Entity Address, City or Town Principal and interest repayments from related party for note receivable Proceeds from Related Party Debt Outstanding net advances Entity Ex Transition Period Entity Ex Transition Period Fair Value Disclosures [Abstract] Earnings Per Share [Abstract] Recently adopted accounting pronouncements policy text block Recently Adopted Accounting Pronouncements Policy [Text Block] Recently Adopted Accounting Pronouncements Fair Value, Inputs, Level 1 [Member] Level 1 Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Expenses Shares Issuable Pursuant To The ESPP [Member] Shares Issuable Pursuant To The ESPP [Member] Shares issuable pursuant to the ESPP. Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities Lessee, Operating Lease, Discount Rate Operating lease discount rate Loan Facility Long-Term Line of Credit Long-Term Line of Credit, Total Amendment Flag Amendment Flag Capital Expenditures Incurred but Not yet Paid Property and equipment purchases included in accounts payable and accrued expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Fair value of RSAs vested Subsequent Event Type [Domain] Subsequent Event Type Remaining principal amount Remaining principal amount Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Document Quarterly Report Document Quarterly Report Accrued Professional Fees Accrued professional fees Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: Imputed interest Less: Imputed interest Earnings Per Share, Policy [Policy Text Block] Net Loss Per Class A Common Share Attributable to Rani Therapeutics Holdings, Inc. Net Loss Per Class A Common Share Attributable to Rani Holdings RMS-ICL Rani Management Service and In Cube Labs LLC [Member] Rani Management Service and In Cube Labs LLC [Member] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents Weighted average discount rate for operating and finance leases calculated at point in time. Operating and Finance Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate Statement [Table] Statement [Table] Operating Lease, Liability, Noncurrent Operating lease liability, less current portion Operating lease liability, net current portion Operating Lease, Liability, Noncurrent, Total Equity Option [Member] Stock Options [Member] Operating Lease, Payments Operating cash flows used for operating leases Number of Operating Segments Number of operating segment Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding Units Outstanding Preferred stock outstanding Shares reserved for future issuance Common Stock, Capital Shares Reserved for Future Issuance Common units reserved for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Outstanding, Weighted-Average Grant Date Fair Value Outstanding, Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested, Weighted-Average Grant Date Fair Value Increase (Decrease) in Deferred Revenue Deferred revenue Warrants to purchase Warrants or rights granted. Warrants Or Rights Granted Warrants Not Settleable in Cash, Fair Value Disclosure Lessee, Operating Leases [Text Block] Leases Series E Warrants Series E Warrants [Member] Series e warrants member. Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining term Service agreement remaining term Liabilities and Equity Total liabilities and stockholders' equity Share Based Compensation Arrangements By Share Based Payment Award Options Grants As Replacement Awards In Period Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Options Grants As Replacement Awards In Period Weighted Average Exercise Price Weighted Average Exercise Price per Share, Granted as replacement awards Accounts Receivable, Related Parties Related party note receivable Plan Name [Domain] Plan Name Fair Value Adjustment of Warrants Change in fair value of preferred unit warrant liability Change in estimated fair value of preferred unit warrant Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and Nature of Business Market capitalization Market Capitalization Market capitalization. Proceeds from employee stock purchase plan Proceeds from Stock Plans Unaudited interim financial information. Unaudited Interim Financial Information Policy [Text Block] Unaudited Interim Condensed Consolidated Financial Statements Deferred Revenue, Total Deferred Revenue Balance at end of period Balance at beginning of period Deferred revenue Sale of Stock [Domain] Sale of Stock Liabilities, Current Total current liabilities Capital Units by Class [Axis] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share [Line Items] Fair Value, Recurring [Member] Fair Value, Recurring Interest Expense, Total Interest Expense Interest expense and other, net Tranches Two Share-Based Payment Arrangement, Tranche Two [Member] Non-controlling Interests Policy Text Block Non-controlling Interests Policy Text Block Non-controlling Interest Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Percentage of tax benefit to be transferred. Percentage Of Tax Benefit To Be Transferred Percentage of tax benefit to be transferred Preferred Stock, Shares Authorized Units Authorized Preferred stock authorized Line of Credit Facility, Description Line of Credit Facility, Description Beneficial Interest Liability Adjustment of tax benefit Entity Small Business Entity Small Business Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Ending Balance Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Compensation Related Costs, Policy [Policy Text Block] Equity-Based Compensation One time patent payment to related party One time patent payment to related party Measurement input probability of exit events member. Measurement Input Probability Of Exit Events [Member] Measurement Input Probability Of Exit Events Assets, Current Total current assets evaluation agreements abstract. Evaluation Agreements [Abstract] Rani LLC-ICL Service Agreement [Member] Rani LLC-ICL Service Agreement [Member] Weighted-average share outstanding basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Fair value measurement discount for lack of marketability. Fair Value Measurement Discount For Lack Of Marketability Fair value measurement discount for lack of marketability RMS-ICL Service Agreement [Member] RMS-ICL Service Agreement [Member] City Area Code City Area Code Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate Intrinsic Value, Outstanding Aggregate Intrinsic Value, Exercisable at September 30, 2021 (in thousands) Aggregate Intrinsic Value, Outstanding, Ending Balance Aggregate Intrinsic Value, Outstanding, Beginning Balance Schedule of Future Principal Payments for the Company's Debt Schedule of Debt [Table Text Block] upfront payment. Upfront Payment Upfront payment Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Number of options, Forfeited Number of options, Forfeited Deferred Revenue, by Arrangement, Disclosure [Table Text Block] Schedule of deferred revenue balance Share-Based Payment Arrangement [Abstract] Liabilities Total liabilities Document Period End Date Document Period End Date Payments of Stock Issuance Costs Stock issuance costs Restricted Stock [Member] Restricted Stock Restricted Stock Awards Weighted Average Grant Date Fair Value, Granted Share based compensation profit interests granted weighted average grant date fair value. Share Based Compensation Profit Interests Granted Weighted Average Grant Date Fair Value Share based compensation arrangement by share based payment award equity instruments other than options grants as replacement of profits interests in period. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants As Replacement Of Profits Interests In Period Granted as replacement of Profits Interests, Number of Shares Accrued Liabilities Total accrued expenses Fair value measurement expected volatility rate. Fair Value Measurement Expected Volatility Rate Fair value measurement expected volatility rate Tranches One Share-Based Payment Arrangement, Tranche One [Member] Common Unit, Authorized Common units, authorized Common Unit Authorized Statistical Measurement [Axis] Statistical Measurement Subsequent Event [Line Items] Deferred financing costs included in accrued expenses. Deferred Financing Costs Included In Accrued Expenses Deferred financing costs included in accrued expenses Stockholders' Equity Attributable to Noncontrolling Interest, Total Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance Stockholders' Equity Attributable to Noncontrolling Interest Non-controlling interest Related Party [Axis] Related Party Assets Total assets Accounting Standards Update 2016-02 [Member] Adoption of Accounting Standards Update 2016-02 [Member] Contract with Customer, Asset, after Allowance for Credit Loss, Total Contract with Customer, Asset, after Allowance for Credit Loss Contract assets Previously Reported [Member] Previously Reported [Member] Derivative, Term of Contract Derivative, term of contract Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., diluted Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Numerator: Exclusive license intellectual property and common unit purchase agreement. Exclusive License Intellectual Property And Common Unit Purchase Agreement [Member] Exclusive License Intellectual Property and Common Unit Purchase Agreement Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Entity Address, Postal Zip Code Entity Address, Postal Zip Code Significant Accounting Policies [Policy Text Block] Significant accounting policies. Significant Accounting Policies Revenue from contract Revenue from Contract with Customer, Including Assessed Tax Revision of Prior Period [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Proceeds from Issuance of Preferred Limited Partners Units Proceeds from issuance of preferred units, net of issuance costs Other Accrued Liabilities Other Deferred offering costs Deferred Offering Costs Conversion of Stock, Shares Converted Conversion of stock, shares Preferred stock, $0.0001 par value - 20,000 shares authorized; none issued and outstanding as of June 30, 2022 and December 31, 2021 Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Carrying Value Equity-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Operating Lease, Liability Total operating lease liability Lease liability Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Exchange Of Common Units Exchange of common units. Exchanges of non-corresponding Class A Units of Rani LLC Effect of exchanges of Paired Interests and non-corresponding Class A Units of Rani LLC Series B Warrants Series B Warrants [Member] Series b warrants member. Statement of Financial Position [Abstract] Entity File Number Entity File Number Stock Issued During Period, Shares, Conversion of Units Effect of exchanges of Paired Interests and non-corresponding Class A Units of Rani LLC Scenario [Domain] Statement of Cash Flows [Abstract] Balance Sheet Related Disclosures [Abstract] Balance sheet Number of Profit Interests Vested Share based compensation number of profits interests vested. Share Based Compensation Number Of Profits Interests Vested Denominator: Weighted Average Number Of Shares Outstanding Basic and Diluted Weighted average number Of shares outstanding basic and diluted Statistical Measurement [Domain] Statistical Measurement Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock Loan Restructuring Modification Name [Domain] Class of Stock [Domain] Class of Stock Conversion of Stock, Shares Issued Exchange of shares issued Subsequent Events [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Measurement Input, Discount for Lack of Marketability [Member] Measurement Input, Discount for Lack of Marketability Weighted Average Remaining Contractual Term, Exercisable at June 30, 2022 (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Proceeds from Issuance of Common Stock Proceeds from issuance of common stock Temporary Equity, Stock Issued During Period, Value, New Issues Issuance of Series E preferred units Exchange of paired interest. Exchange of Paired Interest Exchange of paired interests Class A Units of Rani LLC Exchangeable for Class A Common Stock [Member] Class A Units Of Rani L L C Exchangeable For Class A Common Stock [Member] Class A Units of Rani LLC exchangeable for Class A common stock [Member] Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Canceled and replaced with Restricted Stock Awards. Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Canceled and replaced with Restricted Stock Awards Profits Interests Threshold, Canceled and replaced with restricted stock awards Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentrations of Credit Risk and Other Risks and Uncertainties Antidilutive Securities [Axis] Antidilutive Securities Preferred stock, par value Preferred stock, par or stated value per share Preferred Stock, Par or Stated Value Per Share Lessee, Lease, Description [Line Items] Condensed Financial Statements [Table Text Block] Summary of Consolidated Balance Sheets and Statements of Cash Flow related to Leases Common Class C [Member] Common Class C [Member] Subsequent Events Subsequent Events [Text Block] Tax Receivable Agreement [Member] Tax Receivable Agreement [Member] Tax Receivable Agreement Weighted-average share outstanding diluted Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total Settlement of Series E warrants Settlement of Series E warrants Profits Interests Activity Threshold Forfeitures Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Forfeitures Profits Interests Threshold, Forfeited Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs Balance at end of period Balance at beginning of period General and Administrative General and Administrative Expense [Member] General and Administrative Expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized equity-based compensation expense Exercise of warrant for common units Partners Capital Account Warrants Exercised During Period Value Value of share units issued as a result of the exercise of warrants. Avenue Venture Opportunities Fund, L.P. Avenue Venture Opportunities Fund LP [Member] Avenue Venture Opportunities Fund LP Member Accrued preclinical and clinical trial cost. Accrued Preclinical And Clinical Trial Cost Accrued preclinical and clinical trial costs Current Fiscal Year End Date Current Fiscal Year End Date Depreciation, Total Depreciation Depreciation and amortization Deferred financing costs included in accounts payable and accrued expenses Deferred financing costs included in accounts payable and accrued expenses Deferred financing costs included in accounts payable and accrued expenses. Deferred Financing Costs Included in Accounts Payable and Accrued Expenses Cash and cash equivalents, end of year Cash and cash equivalents, beginning of year Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Ending Balance Total stockholders' equity Beginning Balance Entity Address, Address Line One Entity Address, Address Line One Condensed Cash Flow Statement [Table Text Block] Summary of consolidated balance sheets and statements of cash flow related to leases Noncontrolling Interest [Member] Noncontrolling Interest [Member] South Lake One L L C And Affiliates. South Lake One L L C And Affiliates [Member] South Lake One LLC and Affiliates Increase net of tax assets Increase net of tax assets Income Tax Expense (Benefit), Total Income Tax Expense (Benefit) Income tax expense Income tax expense Increase (Decrease) in Operating Lease Liability Operating lease liabilities Additional Cash Flow Elements [Abstract] Cash Flows Income Taxes Income Tax Disclosure [Text Block] Vesting [Axis] Preferred Stock, Shares Issued, Total Preferred Stock, Shares Issued Preferred stock issued Payments for Operating Activities [Abstract] Cash paid for amounts included in lease liabilities: Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Income Tax Disclosure [Abstract] Agreement termination negotiation period Agreement Termination Negotiation Period Agreement termination negotiation period. Issuance of common stock, shares Stock Issued During Period, Shares, New Issues Issuance of Class A common stock in connection with the IPO, net of issuance costs $10,686, shares Net Asset Value Per Share, Beginning Balance Net Asset Value Per Share, Ending Balance Net Asset Value Per Share Assets, Fair Value Disclosure [Abstract] Assets: Forfeiture of restricted stock awards Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures, Total Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV Member Units [Member] Profits Interests Share based Compensation Arrangement By Share based Payment Award Options Canceled And Replaced Weighted Average Remaining Contractual Term Share based Compensation Arrangement By Share based Payment Award Options Canceled And Replaced Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Canceled and replaced with stock options (in years) Equity [Abstract] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Canceled and replaced with stock options Weighted Average Exercise Price per Share, Forfeited Operating Income (Loss) Loss from operations Interest Rate Debt Instrument, Interest Rate, Stated Percentage Nonvested at June 30, 2022 Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares Related Party [Domain] Related Party Temporary Equity, Ending Balance Temporary Equity, Beginning Balance Temporary Equity, Carrying Amount, Attributable to Parent Convertible preferred units Profits Interests Activity Threshold Grants Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Grants Profits Interests Threshold, Granted Scenario [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Share Based Compensation Profit Interests Forfeitures Weighted Average Grant Date Fair Value. Share Based Compensation Profit Interests Forfeitures Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Forfeited Common stock, voting rights Common Stock, Voting Rights Class of Warrant or Right [Domain] Class of Warrant or Right Entity Filer Category Entity Filer Category Notes Receivable, Related Parties Notes receivable repaid Operating Expenses Total operating expenses Entity Current Reporting Status Entity Current Reporting Status Aggregate Intrinsic Value, Exercisable at June 30, 2022 (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Weighted Average Remaining Contractual Term, Nonvested at June 30, 2022 (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Remaining Contractual Term Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Remaining Contractual Term. Stockholders' Equity Note Disclosure [Text Block] Stockholders' / Members' deficit Change in estimated fair value Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease), Total Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) Stockholders' Equity Attributable to Parent, Beginning Balance Stockholders' Equity Attributable to Parent, Ending Balance Stockholders' Equity Attributable to Parent Total stockholders' equity attributable to Rani Therapeutics Holdings, Inc. Aggregate Intrinsic Value, Nonvested at June 30, 2022 (in thousands) Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Intrinsic Value Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Intrinsic Value. Entity Tax Identification Number Entity Tax Identification Number Income Statement Location [Axis] Income Statement Location Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited, Number of Shares Forfeited, Number of Shares Common stock units issued Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Common stock, value Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Equity Components [Axis] Equity Components Summary of significant accounting policies. Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Consolidated Entities [Domain] Consolidated Entities Accrued Salaries Payroll and related Accounting Standards Update [Domain] Proceeds from Warrant Exercises Proceeds from exercise of warrants for common units Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Prepaid Expense, Current, Total Prepaid Expense, Current Prepaid expenses Leases [Abstract] Consolidation, Variable Interest Entity, Policy [Policy Text Block] Variable Interest Entities Accrued Liabilities [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Related Party Transaction [Axis] Related Party Transaction Operating Expenses [Abstract] Operating expenses Paired Interests [Member] Paired Interests [Member] Paired Interest [Member] Measurement Input, Price Volatility [Member] Measurement Input, Price Volatility Share based compensation arrangement by share based payment award equity instruments other than options grants as replacement of profits interests in period weighted average grant date fair value. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants As Replacement Of Profits Interests In Period Weighted Average Grant Date Fair Value Granted as replacement of Profits Interests, Weighted-Average Grant Date Fair Value Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants Weighted Average Remaining Contractual Term Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants Weighted Average Remaining Contractual Term. Weighted Average Remaining Contractual Term, Granted (in years) Receivables or net contract assets from agreement Receivables, Long-term Contracts or Programs, Total Receivables, Long-Term Contracts or Programs Revenue [Policy Text Block] Revenue Recognition Expiration of Series B warrants Expiration of Series B warrants. Lessee, Operating Lease, Liability, to be Paid [Abstract] Share based compensation arrangement by share based payment award profits interests activity threshold vested. Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Vested Profits Interests Threshold, Vested Document Transition Report Document Transition Report Operating Leases, Rent Expense, Total Operating Leases, Rent Expense Rent expense Sale of Stock, Number of Shares Issued in Transaction Sale of common units Assets, Fair Value Disclosure, Total Assets, Fair Value Disclosure Total assets Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted, Weighted-Average Grant Date Fair Value Aequanimitas Limited Aequanimitas Limited [Member] Aequanimitas Limited Beginning Balance (in units) Ending Balance (in units) Partners' Capital Account, Units Forfeiture of restricted stock awards, shares Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total Stock offering price per share Sale of Stock, Price Per Share Common unit, price per share Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Revision of Prior Period [Domain] Net Income (Loss) Attributable to Parent Net loss attributable to Rani Therapeutics Holdings, Inc. Net loss attributable to Rani Therapeutics Holdings, Inc. Net loss Weighted Average [Member] Weighted Average Operating Lease, Liability, Current Operating lease liability, current portion Less: Operating lease liability, current portion Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Assets and Liabilities Recorded at Fair Value on a Recurring Basis Additional Paid-in Capital [Member] Additional Paid in Capital [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative Related party charges Related Party Transaction Income Expenses From Transactions With Related Party Related Party Transaction Income Expenses From Transactions With Related Party Exercise of warrant for common units, Shares Exercise of warrant for common units, Shares Document Information [Line Items] Summary of Significant Unobservable Inputs used in the Fair Value Measurement of the Series E Preferred Unit Warrant Liability Summary of Significant Unobservable Inputs used in the Fair Value Measurement of the Series E Preferred Unit Warrant Liability Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Entity Registrant Name Entity Registrant Name Share based compensation arrangement by share based payment award options canceled and replaced in period. Share Based Compensation Arrangement By Share Based Payment Award Options Canceled And Replaced In Period Number of Options, Canceled and replaced Number of Options, Canceled and replaced with stock options Liabilities, Fair Value Disclosure, Total Total liabilities Liabilities, Fair Value Disclosure Financial liabilities measured at fair value Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, end of year Cash and cash equivalents, beginning of year Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Earnings Per Share [Text Block] Net Loss Per Share Class of Stock [Axis] Class of Stock Debt Instrument Maturity Date Debt Instrument, Maturity Date Lessee, Lease, Description [Table] Repurchase Agreements, Resale Agreements, Securities Borrowed, and Securities Loaned Disclosure [Text Block] Evaluation Agreements Share-based Payment Arrangement, Noncash Expense, Total Share-Based Payment Arrangement, Noncash Expense Equity-based compensation expense Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards Weighted Average Remaining Contractual Term. Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Term, Granted as replacement awards (in years) Statement of Comprehensive Income [Abstract] Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Total Property, Plant and Equipment, Net Property and equipment, net Award Type [Domain] Statement [Line Items] Statement [Line Items] Operating Lease, Expense Operating lease expenses Paired Interest Paired Interest [Member] Paired Interest Liabilities, Fair Value Disclosure [Abstract] Liabilities: Restricted stock awards. Restricted Stock Awards [Member] Restricted Stock Awards Title of 12(b) Security Title of 12(b) Security Other Operating Activities, Cash Flow Statement Other Operating cash flows used for operating leases Ownership [Domain] Common Unit Common [Member] Common Stock [Member] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities Equity Component [Domain] Equity Component Convertible Preferred Units Convertible Preferred Stock [Member] Convertible Preferred [Member] Rani Therapeutics Holdings Inc. [Member] Parent Company [Member] Revenue from Contract with Customer, Excluding Assessed Tax, Total Revenue from Contract with Customer, Excluding Assessed Tax Contract revenue Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Entity Address, State or Province Entity Address, State or Province Secondary sales transactions. Secondary Sales Transactions [Member] Secondary Sales Transactions Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Document Type Document Type Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for interest Schedule of Related Party Transactions [Table Text Block] Schedule of Amounts Charged for Services and Rent Share Based Compensation Profit Interests Weighted Average Grant Date Fair Value. Share Based Compensation Profit Interests Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Balance at December 31, 2020 Weighted Average Grant Date Fair Value, Balance at September 30, 2021 Entity Shell Company Entity Shell Company InCube Labs, LLC In Cube Labs L L C [Member] ICL ICL Stock-based compensation expense Total equity-based compensation Share-Based Payment Arrangement, Expense Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Preferred Units by Name [Axis] Preferred Units by Name Fair Value, Recurring and Nonrecurring [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Security Exchange Name Security Exchange Name Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Significant Accounting Policies Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Operating activities, net Recognized over a weighted-average period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted Average Remaining Contractual Term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Commitments and Contingencies Disclosure [Abstract] Accrued Taxes Accrued Income Taxes, Current Income tax payable, amount Measurement Input, Expected Term [Member] Measurement Input, Expected Term Takeda Agreement [Member] Takeda Agreement [Member] Takeda Agreement [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units [Member] Lessee, Operating Lease, Liability, Maturity [Table Text Block] Summary of Future Minimum Operating Lease Payments Common Unit, Issued Common Unit Issued Common units holders Common Unit, Outstanding Common stock, shares outstanding Common units outstanding Warrant [Member] Preferred unit warrant liability Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Summary of Restricted Stock Unit and Award Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary Of Stock Option Activity Summary of Stock Options and Options for Common Units Activity New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Schedule of Defined Benefit Plans Disclosures [Table] Schedule Of Defined Benefit Plans Disclosures [Table] Common Stock, Shares, Outstanding Common stock shares outstanding Ending Balance (shares) Beginning Balance (shares) Gain (Loss) on Extinguishment of Debt, Total Gain (Loss) on Extinguishment of Debt Loss from debt extinguishment Loss on extinguishment of debt Loss on extinguishment of debt Series E Preferred Units Series E preferred units. Series E Preferred Units [Member] Fair Value, Inputs, Level 2 [Member] Level 2 Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities Commitments and Contingencies Commitments and contingencies (Note 10) Common stock units issued Common Stock, Shares, Issued, Total Common Stock, Shares, Issued Common stock shares issued Due to Related Parties, Current, Total Due to Related Parties, Current Related party payable Minimum Minimum [Member] Minimum Number of Options, Granted as replacement awards Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards In Period Gross. Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards In Period Gross Lessee, Leases [Policy Text Block] Leases Weighted Average Exercise Price per Share, Exercisable at June 30, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Accounting Standards Update [Axis] Common Class B Common Class B [Member] Common Class B [Member] Accrued Liabilities, Current, Total Accrued Liabilities, Current Accrued expenses Weighted Average Exercise Price per Share, Nonvested at June 30, 2022 Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Cash and Cash Equivalents [Axis] Cash and Cash Equivalents Forfeited, Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Award Type [Axis] Subsequent Event Subsequent Event [Member] Basis of Presentation Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation and Accounting Related Party Transaction [Domain] Related Party Transaction Loss Contingencies [Table] Loss Contingencies [Table] Share Based Compensation Profit Interests Vested Weighted Average Grant Date Fair Value Share Based Compensation Profit Interests Vested Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Vested Nonoperating Income (Expense) [Abstract] Other income (expense), net Issuance of Series E Preferred units, Shares Issuance of Series E Preferred units, Shares Research and Development Expense, Total Research and Development Expense Research and development Future minimum lease payments Lessee, Operating Lease, Liability, to be Paid, Total Lessee, Operating Lease, Liability, to be Paid Total undiscounted future minimum lease payments Rani L L C [Member] Rani LLC. Rani LLC [Member] Entity Central Index Key Entity Central Index Key Share Based Compensation Number Of Profits Interests Outstanding Number. Share Based Compensation Number Of Profits Interests Outstanding Number Number of Profit Interests, Balance at December 31, 2020 Number of Profit Interests, Balance at September 30, 2021 Preferred Units, Class [Domain] Preferred Units, Class Accounting Policies [Abstract] Disaggregation of Revenue [Line Items] Loan Restructuring Modification Name [Axis] Measurement Frequency [Axis] Measurement Frequency Share-Based Payment Arrangement [Text Block] Equity-Based Compensation Subsequent Event [Table] General and Administrative Expense, Total General and Administrative Expense General and administrative Agreement termination period Agreement Termination Period Agreement termination period Measurement Input Type [Domain] Measurement Input Type Organization, Consolidation and Presentation of Financial Statements [Abstract] Document Information [Table] Stock options, outstanding, weighted average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Outstanding, Ending balance Weighted Average Exercise Price per Share, Outstanding, Beginning balance Aggregate principal amount Finance Lease, Principal Payments Weighted average vesting term Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Weighted Average Vesting Period Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Weighted Average Vesting Period Research and Development Research and Development Expense [Member] Research and Development Expense Forecast [Member] Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Retained Earnings [Member] Accumulated Deficit [Member] Members Deficit [Member] Profits interests activity threshold Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Profits Interests Threshold, Balance at December 31, 2020 Profits Interests Threshold, Balance at September 30, 2021 Money Market Funds [Member] Money market funds Measurement Input Type [Axis] Measurement Input Type Effective Income Tax Rate Reconciliation, Percent, Total Effective Income Tax Rate Reconciliation, Percent Effective income tax rate Additional paid-in capital Additional Paid in Capital, Total Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Ending Balance Additional Paid in Capital Entity Interactive Data Current Entity Interactive Data Current Term of Loan security agreement Description Term of Loan security agreement Description Share-based Compensation Arrangement by Share-based Payment Award Options Granted As Replacement Awards in Period Intrinsic Value. Share-based Compensation Arrangement by Share-based Payment Award Options Granted As Replacement Awards in Period Intrinsic Value Aggregate Intrinsic Value, Granted as replacement awards (in thousands) Payment of deferred offering costs Payment of deferred offering costs Payment of deferred offering costs Related Party Transactions Disclosure [Text Block] Related Party Transactions Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosures of non-cash investing and financing activities Related Party Transactions [Abstract] 2022 (remaining six months) Lessee, Operating Lease, Liability, to be Paid, Year One 2022 (from April to December) Members' Equity [Abstract] Stockholders' equity / members' deficit: Temporary Equity, Ending Balance (in units) Temporary Equity, Beginning Balance (in units) Temporary Equity, Shares Outstanding Proceeds from Issuance Initial Public Offering Proceeds from issuance from initial public offering Proceeds from issuance of Class A common stock sold in the IPO, net of issuance costs Local Phone Number Local Phone Number Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Computation of Basic and Diluted Net Loss Per Class A Common Share Debt Disclosure [Abstract] Net Income (Loss) Attributable to Noncontrolling Interest, Total Net Income (Loss) Attributable to Noncontrolling Interest Net loss attributable to non-controlling interest Net loss attributable to non-controlling interest Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Exercisable at June 30, 2022 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Lessee, Operating Lease, Description IPO IPO [Member] IPO [Member] Consolidated Entities [Axis] Consolidated Entities Number Of Tranches Number Of Tranches Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of Options, Granted Number of Options, Unit Grants Stock Issued During Period, Value, Conversion of Units Non-controlling interest adjustment for changes in proportionate ownership in Rani LLC Amount payable for services. Amount Payable For Evaluation Services Amount payable for evaluation services Summary of significant accounting policies. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Unrecognized Tax Benefits, Period Increase (Decrease), Total Unrecognized Tax Benefits, Period Increase (Decrease) Change in uncertain tax position Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary of the Changes in the Fair Value of the Company’s Liability Ending Balance Beginning Balance Partners' Capital, Total Partners' Capital Income Statement Location [Domain] Income Statement Location Evaluation Agreements Evaluation Agreements [Text Block] The entire disclosure for evaluation agreements. Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Outstanding, Number of Shares, Beginning Balance Outstanding, Number of Shares, Ending Balance Increase (Decrease) in Prepaid Expense and Other Assets, Total Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Date of incorporation Entity Incorporation, Date of Incorporation Stock options, outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Number of Options, Outstanding, Ending balance Number of Options, Outstanding, Beginning balance Operating Lease, Lease Income [Abstract] Common Class A [Member] Common Class A Common Class A [Member] Document Fiscal Year Focus Document Fiscal Year Focus Class of Warrant or Right [Axis] Class of Warrant or Right Excess Stock, Shares Outstanding Beneficially number of shares held Lessee, Operating Lease, Liability, to be Paid, Year Two 2023 2023 (totaled) Interest income and other, net Interest and Other Income Vesting [Domain] Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., basic Earnings Per Share, Basic Earnings Per Share, Basic, Total Assets [Abstract] Assets: Increase (Decrease) in Accrued Liabilities, Total Increase (Decrease) in Accrued Liabilities Accrued expenses Equity-Based Compensation Share-Based Payment Arrangement [Member] Limited Liability Company (LLC) Preferred Unit, Issued Convertible Preferred units issued Share Based Compensation Number Of Profits Interests Canceled And Replaced With Restricted Stock Awards. Share Based Compensation Number Of Profits Interests Canceled And Replaced With Restricted Stock Awards Number of Profit Interests, Canceled and replaced with restricted stock Number of Profit Interests, Canceled and replaced with restricted stock awards Sales price and fair value of common units, difference amount. Sales Price And Fair Value Of Common Units Difference Amount Sales price and fair value of common units, difference Liabilities and Equity [Abstract] Liabilities, Convertible Preferred Units and Stockholders' Equity / Members' Deficit Income Taxes Paid, Net, Total Income Taxes Paid, Net Cash paid for income taxes Antidilutive Securities, Name [Domain] Antidilutive Securities, Name Accounts payable Increase (Decrease) in Accounts Payable, Trade Deferred Tax Assets, Net of Valuation Allowance, Total Deferred Tax Assets, Net of Valuation Allowance Deferred tax asset Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Net loss and comprehensive loss Net loss and comprehensive loss Assets, Current [Abstract] Current assets: Outstanding Capital Class A Unit [Member] Outstanding Capital Class A Unit [Member] Warrant exercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV Supplemental Cash Flow Elements [Abstract] Supplemental disclosures of cash flow information Measurement Frequency [Domain] Measurement Frequency Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Related Party Transaction [Line Items] Related Party Transaction [Line Items] Share Based Compensation Number Of Profits Interests Grants In Period Gross. Share Based Compensation Number Of Profits Interests Grants In Period Gross Number of Profit Interests Granted Fair value measurement probability of exit events. Fair Value Measurement Probability Of Exit Events Fair value measurement probability of exit events Cover [Abstract] Limited Liability Company (LLC) Preferred Unit, Authorized Convertible Preferred units authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested, Number of Shares Vested, Number of Shares Liabilities, Current [Abstract] Current liabilities: Maximum Maximum [Member] Maximum General Partner Ownership Interest Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest Tax Receivable Agreement, Policy [Policy Text Block] Tax Receivable Agreement, Policy [Policy Text Block] Tax Receivable Agreement Summary of Components of Equity-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Common stock, conversion basis Common Stock, Conversion Basis Common unit conversion basis Limited Liability Company (LLC) Preferred Unit, Outstanding Convertible Preferred units outstanding Fair Value, Inputs, Level 3 [Member] Level 3 Use of Estimates, Policy [Policy Text Block] Use of Estimates Tabular disclosure for profits interests activity. Schedule Of Share Based Compensation Profits Interests Activity Table [Text Block] Summary of Profits Interests Activity Derivative Liability, Fair Value, Gross Liability, Total Derivative Liability, Subject to Master Netting Arrangement, before Offset Fair Value (in thousands) Capital Unit, Class A [Member] Class A unit Member Share Based Compensation Profit Interests Canceled And Replaced With Restricted Stock Awards Weighted Average Grant Date Fair Value. Share Based Compensation Profit Interests Canceled And Replaced With Restricted Stock Awards Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Canceled and replaced with restricted stock awards Continuing LLC Owners Continuing LLC Owners [Member] Share Based Compensation Number Of Profits Interests Forfeitures. Share Based Compensation Number Of Profits Interests Forfeitures Number of Profit Interests Forfeited Exchange of Class A units Exchange of Class A units Exchange of Class A Units of Rani LLC Exchanges of Paired Interests and non-corresponding Class A Units of Rani LLC Settlement of Series E warrants. Settlement of Series E warrant Settlement of Series E warrants 2021 Employee Stock Purchase Plan Two Thousand And Twenty One Employee Stock Purchase Plan [Member] Two Thousand And Twenty One Employee Stock Purchase Plan [Member] Common Stock, Shares Authorized Common stock shares authorized Trading Symbol Trading Symbol Ownership [Axis] Novartis Agreement [Member] Novartis Agreement [Member] Novartis Agreement [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period, Intrinsic Value Amount of accumulated difference between fair value of underlying shares on dates of grant and grant price on options granted (or share units converted) into shares. Aggregate Intrinsic Value, Granted (in thousands) Service agreement term Service Agreement Term Service agreement term. Subsequent Event Type [Axis] Subsequent Event Type Operating Lease, Right-of-Use Asset, Amortization Expense Non-cash operating lease expense Accounts Payable, Current, Total Accounts Payable, Current Accounts payable Plan Name [Axis] Plan Name Schedule of Related Party Transactions, by Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Aggregate desired patent acquisition Aggregate desired patent acquisition Capital Unit, Class [Domain] Common Stock, Par or Stated Value Per Share Common stock par value Members' Deficit [Member] Members' Deficit. Members' Deficit [Member] Comprehensive Income, Policy [Policy Text Block] Comprehensive Loss Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted, Number of Shares Granted, number of shares Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Granted Weighted Average Exercise Price per Share, Unit Grants Increase (Decrease) in Accounts Payable, Related Parties Related party payable Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive securities excluded from computation of diluted net loss per share Exchanged paired interests for the Company's Class A common stock